How ?

INGESTEM includes:

  • ajp70791
  • Four iPSC production platforms (ESTeam, I-Stem, PrimaStem, SAFE-IPS)
  • Four  tissue bioengineering platforms (ESTeam, I-Stem, IGBMC, SAFE-IPS)
  • Two high-throughput screening platforms (I-Stem, IGBMC)
  • One transgenic platform (PrimaStem)
  • Two production platforms of future Advanced-Therapy Medicinal Products (ATMPs) for clinical trials phase I-II (ESTeam, I-Stem)

All of these platforms work in a coordinated manner according to their expertise and the organizational scheme as below.